Assessment of the heat stability of seven rapid HIV assays

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 7, 2011, Pages 388-395

  Learmonth, Kate M ^a,c   Chiu, Chris Y ^a   Galang, Hazel ^b   Nawang, Mohammad J ^b   Dax, Elizabeth M ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

HIV and AIDS; Rapid diagnostic tests; Temperature stability

Indexed keywords

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENVIRONMENTAL TEMPERATURE; HEAT SHOCK; HIGH TEMPERATURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS RAPID DIAGNOSTIC TEST; IMMUNOASSAY; OUTCOME ASSESSMENT; THERMOSTABILITY;

HIV ANTIBODIES; HIV SEROPOSITIVITY; HIV-1; HOT TEMPERATURE; HUMANS; REAGENT KITS, DIAGNOSTIC; TROPICAL CLIMATE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80955177184     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.04.005     Document Type: Article

References (16)

1. Chiodini P.L., Bowers K., Jorgensen P., Barnwell J.W., Grady K.K., Luchavez J., et al. The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests. Trans R Soc Trop Med Hyg 2007, 101:331-337.
2. Kassler W.J., Haley C., Jones W.K., Gerber A.R., Kennedy E.J., George J.R. Performance of a rapid, on-site human immunodeficiency virus antibody assay in a public health setting. J Clin Microbiol 1995, 33:2899-2902.
3. WHO Priority interventions: HIV/AIDS prevention, treatment and care in the health sector V1.2 2009, World Health Organization, Geneva.
4. WHO, Joint United Nations Programme on HIV/AIDS (UNAIDS). HIV Assays: Operational Characteristics (Phase I) HIV Assays reports 11-15. Geneva: World Health Organization; 2002.
5. Aghokeng A.F., Ewane L., Awazi B., Nanfack A., Delaporte E., Peeters M., et al. Evaluation of four simple/rapid assays and two fourth-generation ELISAs for the identification of HIV infection on a serum panel representing the HIV-1 group M genetic diversity in Cameroon. J Acquir Immune Defic Syndr 2004, 37:1632-1640.
6. Arai H., Petchclai B., Khupulsup K., Kurimura T., Takeda K. Evaluation of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus. J Clin Microbiol 1999, 37:367-370.
7. Ferreira Junior O.C., Ferreira C., Riedel M., Widolin M.R., Barbosa-Junior A. Evaluation of rapid tests for anti-HIV detection in Brazil. Aids 2005, 19(Suppl 4):S70-S75.
8. Holguin A. Evaluation of three rapid tests for detection of antibodies to HIV-1 non-B subtypes. J Virol Methods 2004, 115:105-107.
9. Palmer C.J., Dubon J.M., Koenig E., Perez E., Ager A., Jayaweera D., et al. Field evaluation of the Determine rapid human immunodeficiency virus diagnostic test in Honduras and the Dominican Republic. J Clin Microbiol 1999, 37:3698-3700.
10. Rouet F., Ekouevi D.K., Inwoley A., Chaix M.L., Burgard M., Bequet L., et al. Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women. J Clin Microbiol 2004, 42:4147-4153.
11. WHO Priority interventions: HIV/AIDS prevention, treatment and care in the health sector 2010, World Health Organization, Geneva.
12. Jorgensen P., Chanthap L., Rebueno A., Tsuyuoka R., Bell D. Malaria rapid diagnostic tests in tropical climates: the need for a cool chain. Am J Trop Med Hyg 2006, 74:750-754.
13. Gray R.H., Makumbi F., Serwadda D., Lutalo T., Nalugoda F., Opendi P., et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ 2007, 335:188.
14. Meles H., Wolday D., Fontanet A., Tsegaye A., Tilahun T., Aklilu M., et al. Indeterminate human immunodeficiency virus Western blot profiles in Ethiopians with discordant screening-assay results. Clin Diagn Lab Immunol 2002, 9:160-163.
15. Dax E.M., O'Connell R. Standardisation of subjectively scored HIV immunoassays: developing a quality assurance program to assist in reproducible interpretation of results using an anti-HIV particle agglutination assay as a model. J Virol Methods 1999, 82:113-118.
16. WHO, US Department of Health and Human Services Centres for Disease Control and Prevention (CDC). Guidelines for assuring the accuracy and reliability of HIV rapid testing: applying a quality system approach. Geneva: World Health Organization; 2005.